2018 annual financial data
ImmunityBio 2018 Operating margin
Direct answer
Operating margin was -209,338.3%.
Operating income was -98,389,000 USD and net income was -96,226,000 USD.
Operating cash flow was -63,381,000 USD.
Get free ImmunityBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 47,000 USD
- Operating income
- -98,389,000 USD
- Net income
- -96,226,000 USD
- Operating cash flow
- -63,381,000 USD